Are SGLT2 inhibitors or GLP-1 receptor agonists more appropriate as a second-line therapy in type 2 diabetes?

被引：6
|
作者：
Munir, Kashif M. [1 ]
Davis, Stephen N. [2 ]
机构：
[1] Univ Maryland, Sch Med, Ctr Diabet & Endocrinol, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, 22 South Greene St, Baltimore, MD 21201 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2018年 / 19卷 / 08期
关键词：
GLP-1 receptor agonist; SGLT2; inhibitor; type; 2; diabetes; cardiovascular outcomes; GLUCOSE-LOWERING DRUGS; CARDIOVASCULAR OUTCOMES; CVD-REAL; MORTALITY; EMPAGLIFLOZIN; LIRAGLUTIDE;
D O I：
10.1080/14656566.2018.1475559
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：773 / 777
页数：5
相关论文
共 50 条
  • [21] Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
    Cardoso, Pedro
    Young, Katie G.
    Nair, Anand T. N.
    Hopkins, Rhian
    Mcgovern, Andrew P.
    Haider, Eram
    Karunaratne, Piyumanga
    Donnelly, Louise
    Mateen, Bilal A.
    Sattar, Naveed
    Holman, Rury R.
    Bowden, Jack
    Hattersley, Andrew T.
    Pearson, Ewan R.
    Jones, Angus G.
    Shields, Beverley M.
    McKinley, Trevelyan J.
    Dennis, John M.
    DIABETOLOGIA, 2024, 67 (05) : 822 - 836
  • [22] GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysis
    Banerjee, Mainak
    Pal, Rimesh
    Maisnam, Indira
    Mukhopadhyay, Satinath
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [23] SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation
    Chan, Yi-Hsin
    Chao, Tze-Fan
    Chen, Shao-Wei
    Lee, Hsin-Fu
    Li, Pei-Ru
    Yeh, Yung-Hsin
    Kuo, Chi-Tai
    See, Lai-Chu
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10) : 2617 - 2629
  • [24] Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
    Singh, Awadhesh Kumar
    Singh, Ritu
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (06): : 329 - 342
  • [25] Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Li, Jiahua
    Albajrami, Oltjon
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (11): : 1678 - 1688
  • [26] SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
    Rolek, Bartosz
    Haber, Mateusz
    Gajewska, Magdalena
    Rogula, Sylwester
    Pietrasik, Arkadiusz
    Gasecka, Aleksandra
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (08)
  • [27] Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes
    Lajara, Rosemarie
    POSTGRADUATE MEDICINE, 2019, 131 (08) : 555 - 565
  • [28] Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes
    Norgaard, Caroline H.
    Starkopf, Liis
    Gerds, Thomas A.
    Vestergaard, Peter
    Bonde, Anders N.
    Fosbol, Emil
    Kober, Lars
    Wong, Nathan D.
    Torp-Pedersen, Christian
    Lee, Christina J-Y
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (06) : 549 - 556
  • [29] SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease
    Sajja, Aparna P.
    Dey, Amit K.
    Guha, Avirup
    Elnabawi, Youssef
    Joshi, Aditya A.
    Kalra, Ankur
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (05) : 422 - 427
  • [30] Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study
    Falkentoft, Alexander C.
    Andersen, Julie
    Malik, Mariam Elmegaard
    Selmer, Christian
    Gaede, Peter Haulund
    Staehr, Peter Bisgaard
    Hlatky, Mark A.
    Fosbol, Emil
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    Gerds, Thomas Alexander
    Schou, Morten
    Bruun, Niels E.
    Ruwald, Anne-Christine
    LANCET REGIONAL HEALTH-EUROPE, 2022, 14
12345